A change in the membership of the federal government's HTA review reference committee. What does it say about the review and what does it mean? Still waiting for final outcomes ahead of the 1 April price changes and a question from the audience about what patients can do to ensure their voices are heard.

Latest Video
New Stories
-
Health stakeholders welcome the reappointment of Mark Butler
May 12, 2025 - - Latest News -
Pharma stocks rise in response to Trump's 'MFN' executive order
May 12, 2025 - - Latest News -
Lilly touts weight management results in new head-to-head study
May 12, 2025 - - Latest News -
Experienced industry executive appointed chair of Tryptamine Therapeutics
May 12, 2025 - - Australian Biotech -
Monash scientists secure MRFF funding to find new medicines for dementia by 'lighting up' human brain cells
May 12, 2025 - -
Radiopharm Theranostics accelerates 177Lu-RAD204 Phase 1 dose escalation trial
May 12, 2025 - - Australian Biotech -
An already busy fixed ministerial bandwidth, just got much busier
May 12, 2025 - - Latest News